胰腺癌放疗加量策略:单纯提高剂量、提高相对生物效应还是两者兼顾?
本文综述离子束治疗胰腺癌的现有知识与研究,指出局部晚期胰腺癌预后差,常规放疗可缩小肿瘤体积,但需推进离子束治疗以实现剂量升级,从而提高局部控制率并缩小肿瘤。离子束治疗物理特性优越,但存在分次内和分次间鲁棒性挑战,需进一步研究运动缓解与生物治疗计划以确定最佳临床条件。
要点
- 局部晚期胰腺癌预后差,常规放疗可缩小肿瘤,但需离子束治疗实现剂量升级。
- 离子束治疗物理特性优越,但存在分次内和分次间鲁棒性挑战。
- 初步临床结果有前景,需进一步研究运动缓解和生物治疗计划。
核心结论
- 离子束治疗胰腺癌初步临床结果有前景,但需进一步研究运动缓解和生物治疗计划以确定最佳临床条件。
研究设计与样本
- 本文为综述,总结离子束治疗胰腺癌的当前知识与研究。
主要发现
- 局部晚期胰腺癌预后差,放疗可缩小肿瘤体积,但需离子束治疗实现剂量升级以提高局部控制率和缩小肿瘤。
- 离子束治疗物理特性优越,但存在分次内和分次间鲁棒性挑战。
临床怎么用
- 离子束治疗胰腺癌需关注运动缓解和生物治疗计划,以确定最佳临床条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local control rates and downsizing of the tumor itself. Ion beam therapy with its highly promising physical properties is also accompanied by distinct inter- and intrafractional challenges in case of robustness. First clinical results are promising, but further research in motion mitigation and biological treatment planning is necessary, in order to determine the best clinical rationales and conditions of ion beam therapy of pancreatic cancer. This review summarizes the current knowledge and studies on ion beam therapy of pancreatic cancer.
引用
- Dreher C, Habermehl D, Jäkel O, et al. Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both? Radiat Oncol. 2017. PMID: 29282139. doi:10.1186/s13014-017-0945-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。